News
The U.S. Food and Drug Administration on Monday approved Merck's preventive antibody shot to protect infants up to one year ...
9hon MSN
Merck’s shot will compete against a similar blockbuster treatment from Sanofi and AstraZeneca called Beyfortus.
12h
GlobalData on MSNAstraZeneca and Pangaea partner for AI detection of hypophosphatasiaAstraZeneca’s rare disease business, Alexion, has partnered with British health tech Pangaea Data to fund the startup’s ...
With precious little to report out of Sino-U.S. trade talks in London, investors are ready to pounce on almost any sign a ...
20h
GlobalData on MSNEC approves AstraZeneca’s acalabrutinib combo for CLLThe EC has granted approval for a fixed-duration regimen of AstraZeneca's Calquence (acalabrutinib) plus venetoclax.
Sanofi boosts Beyfortus output for RSV season while Dupixent trial shows strong eczema relief in patients with skin of color.
Meanwhile, Sanofi has pointed to Beyfortus’ 75% reduction in the incidence of MALRI versus Enflosia’s figure of 60%. The ...
The astraszenecaglobal.xyz scam is abusing the real pharmaceutical giant’s name to run a fake investment scheme targeting ...
3hon MSN
Sanjay Kumar Bohra has stepped down from his role as Chief Financial Officer (CFO) of Force Motors, effective June 9. The ...
A major challenge that the FTSE 100 continues to face is the very weak levels of liquidity in stocks traded in London.
'We are in a good spot': Gilead's new chief medical officer is committed to pipeline diversification
Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results